NEW YORK, NY / ACCESS Newswire / May 8, 2025 / If you suffered a loss on your Viatris Inc. (NASDAQ:VTRS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:

You might also be interested in reading Krystal Biotech sees global VYJUVEK expansion and expects Q3 revenue dip before renewed growth.